Please provide your email address to receive an email when new articles are posted on . Dexrazoxane appeared to have a cardioprotective effect almost 2 decades after exposure to anthracyclines among a ...
Anthracyclines such as doxorubicin are highly effective chemotherapy agents used to treat many common malignancies. However, their use is limited by cardiotoxicity. In this video, Aarti Asnani, MD, a ...
Natural history of node-positive breast cancer: the curability of small cancers with a limited number of positive nodes. Dexrazoxane was found effective in reducing doxorubicin cardiotoxicity when ...
Family history of cardiovascular disease and cardiovascular comorbidities risk in a pediatric cancer population. Risk of subsequent breast cancer after radiotherapy according to hormone-receptor ...
Although the phosphatidyl-inositol-3-kinase (PI3K)/Akt pathway is essential for conferring cardioprotection in response to ischemic preconditioning (IP), the role of PI3K/Akt signaling in the ...
What is the best choice for cardioprotection in a woman aged 75 years with episodic symptomatic angina, MI one year earlier and a sensitivity to nitroglycerin patches (i.e., skin erythema, burning, ...
After a modest early signal of benefit, candesartan cilexetil (Atacand, Cheplapharm) showed no effect on key markers of heart health 2 years after treatment in patients with early-stage breast cancer ...
Please provide your email address to receive an email when new articles are posted on . Soy protein plus ketoanalogues of essential amino acids produced a larger effect on nephroprotection and ...
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results